Form 4 for CYTK CYTOKINETICS INC
Accepted 2024-12-05 00:00:00 ET · period of report 2024-12-03 · accession 0001127602-24-028713 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-05 | 2024-12-03 | CYTK | Callos Andrew | EVP, Chief Commercial Off | F - Tax | $51.51 | -1,351 | 65.7K | -2% | -$69.6K | |
| M | 2024-12-05 | 2024-12-03 | CYTK | Callos Andrew | EVP, Chief Commercial Off | A - Grant | $0.00 | +6,353 | 68.9K | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-03 | F | D | 1,351 | $51.51 | 65,712 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-03 | A | A | 3,176 | $0.00 | 67,063 | D | — | — | |
| 3 | Common | Common Stock | 2024-12-03 | A | A | 3,177 | $0.00 | 68,889 | D | — | — |